Acute doses of 3 and 6 mg/kg caffeine produce outcome- and phase-specific improvements in male 100-m sprinters: A randomized, double-blind, placebo-controlled crossover trial
PLOS One · 10.11.2026 · 21 (11) · e0361864
DOI: 10.1371/journal.pone.0361864 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, online erschienen am 10.11.2026. Verfasst von Tao Mei und 2 weiteren Autor:innen. Beteiligte Einrichtung: China Institute of Sport and Health Science, Beijing Sport University, Beijing, China. Hauptthemen laut MEDLINE: Caffeine, Running, Athletic Performance. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Humanities and Social Sciences Research Project of the Ministry of Education of China, Zhejiang “Pioneer” and “Leading Goose” R&D Program.
Abstract (Originalsprache)
Evidence is limited on whether commonly used caffeine doses provide uniform benefits across sprint phases and performance outcomes in trained sprinters. We compared the acute effects of 3 and 6 mg/kg caffeine in a randomized, double-blind, placebo-controlled, three-condition crossover trial. Twenty-one male 100-m sprinters completed placebo, 3 mg/kg caffeine, and 6 mg/kg caffeine trials separated by at least 7 days. Sixty minutes after ingestion, participants completed two maximal 60-m sprints, followed by countermovement jump, squat jump, and 10-s Wingate tests. Sprint times, derived split times, start reaction time, starting-block rate of force development, stride variables, and perceived exertion were also assessed. Linear mixed-effects models adjusting for treatment period and randomized sequence showed clear treatment effects for cumulative 10-, 30-, and 60-m times (all p < 0.001). Relative to placebo, 3 mg/kg shortened these times by 0.056, 0.083, and 0.123 s, whereas 6 mg/kg shortened them by 0.075, 0.115, and 0.175 s. Compared with 3 mg/kg, 6 mg/kg further reduced 30- and 60-m times by 0.032 and 0.052 s, respectively, whereas the additional 0.019-s reduction at 10 m was not statistically significant in the primary mixed-effects model. Both doses improved reaction time, perceived exertion, jump height, Wingate peak and mean power, and starting-block rate of force development relative to placebo. Additional benefits of 6 mg/kg were evident for jump height and rate of force development, but not for reaction time, perceived exertion, or Wingate mean power; Wingate peak power did not improve further with the higher dose. Stride length and frequency were unchanged. These findings indicate outcome-specific dose responses, with 3 mg/kg improving multiple performance outcomes and 6 mg/kg providing additional benefits most consistently for vertical jump height, starting-block rate of force development, and cumulative performance over the first 60 m. Trial registration Chinese Clinical Trial Registry, ChiCTR2600128594 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- China Institute of Sport and Health Science, Beijing Sport University, Beijing, China.
- Beijing Key Laboratory of Sports Performance and Skill Assessment, Beijing Sport University, Beijing, China.
- Key Laboratory for Performance Training and Recovery of the General Administration of Sport of China, Beijing Sport University, Beijing, China.
- Football College, Hebei Sport University, Shijiazhuang, China.
ORCID-Profile: Tao Mei, Xiangang Yang
Förderung
- Humanities and Social Sciences Research Project of the Ministry of Education of China
- Zhejiang “Pioneer” and “Leading Goose” R&D Program
Zitieren
APA
Mei, T., Li, J., & Yang, X. (2026). Acute doses of 3 and 6 mg/kg caffeine produce outcome- and phase-specific improvements in male 100-m sprinters: A randomized, double-blind, placebo-controlled crossover trial. PLOS One, 21(11), e0361864. https://doi.org/10.1371/journal.pone.0361864
Vancouver
Mei T, Li J, Yang X. Acute doses of 3 and 6 mg/kg caffeine produce outcome- and phase-specific improvements in male 100-m sprinters: A randomized, double-blind, placebo-controlled crossover trial. PLOS One. 2026;21(11):e0361864. doi:10.1371/journal.pone.0361864
BibTeX
@article{Mei2026,
author = {Mei, Tao and Li, Jianing and Yang, Xiangang},
title = {Acute doses of 3 and 6 mg/kg caffeine produce outcome- and phase-specific improvements in male 100-m sprinters: A randomized, double-blind, placebo-controlled crossover trial},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0361864},
doi = {10.1371/journal.pone.0361864}
}
EUVIMED